ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PATH Nupathe Inc. (MM)

4.25
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Nupathe Inc. (MM) NASDAQ:PATH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.25 0 01:00:00

NUPATHE INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of NuPathe Inc. (PATH) Over the Proposed Sale of the...

27/12/2013 6:25pm

Business Wire


Nupathe Inc. (MM) (NASDAQ:PATH)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Nupathe Inc. (MM) Charts.

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of NuPathe, Inc.

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of NuPathe Inc. (“NuPathe” or the “Company”) (NasdaqGM: PATH) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Endo Health Solutions (NasdaqGS: ENDP) in a cash deal valued at approximately $105 million. Under the terms of the proposed transaction, NuPathe’s stockholders will receive $2.85 for each share of NuPathe common stock they own, while according to Yahoo! Finance, at least one financial analyst has set a price target of $8.00 for NuPathe.

Request more information now by clicking here: www.faruqilaw.com/PATH. There is no cost or obligation to you.

The investigation focuses on whether NuPathe’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether and by how much this proposed transaction undervalues the Company to the detriment of NuPathe’s shareholders.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

If you own common stock in NuPathe and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/PATH or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

Faruqi & Faruqi, LLP369 Lexington Avenue, 10th FloorNew York, NY 10017Attn: Juan E. Monteverde, Esq.jmonteverde@faruqilaw.comToll Free: 877-247-4292Phone: 212-983-9330

1 Year Nupathe Inc. (MM) Chart

1 Year Nupathe Inc. (MM) Chart

1 Month Nupathe Inc. (MM) Chart

1 Month Nupathe Inc. (MM) Chart

Your Recent History

Delayed Upgrade Clock